The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,352.00
Bid: 12,348.00
Ask: 12,352.00
Change: -12.00 (-0.10%)
Spread: 4.00 (0.032%)
Open: 12,358.00
High: 12,376.00
Low: 12,276.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK sends first of 100 million promised vaccine doses to poorer nations

Wed, 28th Jul 2021 16:35

(Alliance News) - The first batch of excess coronavirus vaccines from Britain will be shipped off to "vulnerable" nations and Commonwealth allies this week, the UK Foreign Secretary has announced.

Leaders of the major industrialised nations at the G7 summit in Cornwall pledged more than one billion doses of Covid-19 vaccine – 870 million jabs shared directly and the rest through funding to the Covax initiative – to poorer countries.

Prime Minister Boris Johnson confirmed the UK's contribution to the one billion dose pledge is another 100 million vaccines from now to next June, with Dominic Raab announcing on Wednesday that the first shipment of nine million spare Oxford-AstraZeneca PLC will be made this week.

And in a message to western countries who have unused stockpiles of AstraZeneca jabs, Raab stressed that bodies ranging from the World Health Organisation to the European Medicines Agency had approved the British-designed vaccine as safe, arguing it was "crucially important" for all nations to vaccinate their populations.

It comes as parts of Australia have been forced to go back into lockdown despite the UK ally having three million unboxed doses of the AstraZeneca inoculation stored, according to reports.

Fears about the Oxford jab's side effects, including an increased risk of blood clots, have seen it shunned in some wealthy countries.

The Foreign Secretary visited an AstraZeneca manufacturing site in Oxford on Wednesday to announce that the first despatch of excess UK doses will be making their way to poorer nations this week – with five million to be distributed via the WHO's Covax scheme and another four million bilaterally.

Speaking to the PA news agency after the visit, the Cabinet minister said: "We succeeded in double-vaccinating 70% of the adult population, the UK economy is bouncing back but we know we're not going to be safe in the UK until everyone is safe.

"That is why we have been leading the (international) vaccine rollout to give enough doses to get the world vaccinated by the middle of next year, rather than the current trajectory, which is the end of 2024."

Raab said the UK was delivering on its G7 pledge of sending 100 million surplus vaccines to the "poorest and most vulnerable countries around the world" before the middle of 2022.

"The first nine million doses will be going on Friday to countries from vulnerable countries in the Indo-Pacific, such as Laos, Cambodia, key partners like Indonesia, right the way through the Commonwealth countries from Kenya to Jamaica," the Cabinet minister added.

"I think what it shows, as well as the domestic rollout and the importance of coming out of the lockdowns in the UK, is that global Britain is also a lifesaving force for good in the world."

Indonesia will receive 600,000 doses of those being handed out bilaterally, 300,000 will be sent to Jamaica and 817,000 are to be transported to Kenya, among other countries, the Foreign Office said.

Raab, who is also First Secretary of State, joined the prime minister and fellow Cabinet colleague Therese Coffey in refusing to repeat Michael Gove's assertion that it was "selfish" to refuse a vaccine.

The Chancellor of the Duchy of Lancaster's comment comes as the government prepares to make being double-jabbed a condition of entry to nightclubs in September in a bid to increase the number of young people coming forward for inoculation.

Asked what he made of Gove's remark, Raab told PA: "Look, I think people should get vaccinated for their own self-interest because it is far safer to do so, and I would encourage everyone to do so."

Professor Sir John Bell said the UK's decision to send unneeded Covid-19 vaccines to developing nations was "long overdue" and would help guard against new variants of the virus forming.

The Regius Professor of Medicine at Oxford University told BBC Radio 4's World At One programme: "I think it is a bit self-indulgent, to be honest, of western countries fretting about these kinds of issues (what rights to afford the fully vaccinated) when the vast majority of the globe remains completely unvaccinated, with massive levels of viral replication sweeping through the population.

"If you want variants, you've got the perfect storm for that, and it is not in Watford – it is in Zimbabwe and Rwanda and South Africa."

By Patrick Daly, PA Political Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.